Introduction {#s1}
============

The intestine plays a crucial role in digesting and absorbing nutrients, balancing microbiota, protecting immunological functions and serves as a barrier against harmful pathogens and antigens (Vancamelbeke and Vermeire, [@B31]). Lipopolysaccharide (LPS/endotoxin), the major constituent of the outer membrane of gram-negative bacteria, is a common trigger of intestinal mucosal injury. The LPS-induced cytokine release leads to the pathophysiologic derangement associated with intestinal mucosal injury. Many cellular signals that are activated by Gram-negative bacteria are contributed to LPS. Not only does LPS trigger inflammatory responses, but it also activates pro-apoptotic signals in macrophages, endothelial cells, epithelial cells and immune cells (Ma et al., [@B18]; Plociennikowska et al., [@B25]). NF-κB plays a critical role in immune and inflammatory responses. It has been known to be present in most cell types and many of the inflammatory proteins expressed are regulated by NF-κB (Hayden and Ghosh, [@B14]).

Despite a growing understanding of the pathophysiology of intestinal mucosal damage, its molecular regulatory mechanisms in induction of cytokines expression and activation/recruitment of inflammatory in intestinal mucosal damage remain elusive. However, there is a need for innovative anti-inflammatory therapeutic protocols and some previous studies have shown that intestinal mucosal damage is associated with persistent activation of NF-κB (Medicherla et al., [@B22]). Therefore, the remedial measures of anti-inflammatory properties based on the NF-κB signaling pathway may be a potentially useful option. Likewise, growing evidence suggests that numerous components of Chinese medicinal herbs exert excellent anti-inflammatory effects through the negative regulation of NF-κB signaling pathway (Shen et al., [@B28]).

*Gardenia jasminoides*, an evergreen tree that belongs to the Rubiaceae family, is cultivated in multiple areas in China, with a Chinese name of Zhi Zi. It grows in many temperate regions and has fragrant white flowers (Ma et al., [@B19]). It is not only used as natural yellow dyes for many years (Chen et al., [@B2]; Ma et al., [@B19]), but also has various biological activities, such as antidiabetic (Wu et al., [@B32]), anti-inflammatory (Oliveira et al., [@B24]), anti-depression (Tao et al., [@B30]), and antioxidant properties (Guo et al., [@B13]), and improvement of the quality of sleep (Zhang et al., [@B35]). It is commonly used in traditional Chinese medicine. However, there are not so many reports studies focusing on the decoction of *Gardenia jasminoides*. Some studies showed that Geniposide inhibited Lipopolysaccharide-induced Apoptosis (Song et al., [@B29]). It is still not elucidated whether oral administration of *Gardenia jasminoides* decoction (GD) could provide a protective effect during intestinal mucosal injury and what is the underlying mechanism. The current study, we investigated the preventive effect of GD in LPS induced experimental intestinal mucosal injury in mice.

Materials and Methods {#s2}
=====================

Reagents
--------

The main reagents and antibodies used in our experiments are as follows: Antibodies recognizing NF-κB p65 (10745-1-AP) was purchased from Proteintech and β-actin was from Cell Signaling (Beverly, MA, USA). Secondary antibody was from Biosynthesis (Beijing, China). LPS from Escherichia coli 055:B5 was obtained from Sigma (St. Louis, MO, USA). LPS was suspended in physiological saline and stored as a 20 mg/ml stock. Animals were weighed before injecting LPS and the LPS of each animal was diluted to an appropriate dose. Dilute solution prior to injection were into normal saline.

Animals
-------

Animal protocols were approved by Heilongjiang Bayi Agricultural University\'s Institutional Animal Care and Use Committee. A total of 50 male ICR mice (22--25 g body weight) were purchased from the Animal Experiment Center of HARBIN MEDICAL UNIVERSITY (Daqing, China). All animals were kept in the temperature controlled room with 12 h dark/light cycles and maintained under specific-pathogen-free conditions and were given a standard mice diet and tap water for 1 week before experiments.

Preparation of *G. jasminoides* Decoction
-----------------------------------------

*Gardenia jasminoides* were purchased from Fu Rui Bang Chinese Medicine Co., Ltd. (Daqing, China). The general preparation procedure of *G. Jasminoides* decoction (GD) is as follows (Qin et al., [@B27]; Yu et al., [@B34]; Cui et al., [@B5]). Briefly, 100 g *G. jasminoides* Fruit were extracted by refluxing with water (1:10, w/v) for 2 h following sonication for 30 min, and then the extraction solutions were combined to be filtered and concentrated to 100 mL under reduced pressure. The concentrations of the residues were 1 g/mL for *G. jasminoides* fruit (Tao et al., [@B30]). Finally, the concentration be adjusted to the required with distilled water for intragastrical administration. After being autoclaved at 100°C for 20 min, the stock solution was stored at 4°C.

LC/MS Analysis
--------------

The samples were thawed at room temperature, 100 μL of them was then transferred into Centrifuge Tubes (1.5 mL) by pipette. All samples were extracted with 300 μL of methanol, and 10 μL of internal standard (3 mg/mL, DL-o-Chlorophenylalanine) was added. The samples were then ultra-sonicated at 4 K Hz on ice bath for 30 min. The samples were vortexes for 30 s, and centrifuged at 12,000 rpm and 4°C for 15 min. Two hundred microliter of supernatant was transferred to vial for LC-MS analysis. Analysis platform: LC-MS (Thermo, Ultimate 3000LC, Orbitrap Elite) Column: Waters ACQUITYUPLC HSS T3column (2.1 mm × 100 mm, 1.8 μm) Chromatographic separation conditions: Column temperature: 40°C; Flow rate: 0.3 mL/min; Mobile phase A: water + 0.1% formic acid; Mobile phase B: acetonitrile + 0.1% formic acid; Injection volume: 4 μL; Automatic injector temperature: 4°C. The data was performed feature extraction and preprocessed with Compound Discoverer software (Thermo), and then normalized and edited into two-dimensional data matrix by excel 2010 software, including Retention time(RT), Compound Molecular Weight (comp MW), Observations (samples) and peak intensity.

Grouping and Treatment
----------------------

In experiments, animals were randomly divided into five groups: the normal control group, the LPS group, and GD high-dose, medium-dose and low-dose groups.GD-treated groups were given *G. jasminoides* decoction by intragastric administration once daily for 3 d. The normal control group and the LPS group were orally administered with double distilled water. One hour after the oral administration on 3 d, the control group received intraperitoneal injection of normal saline, while the other group received intraperitoneal injection of LPS (Escherichia coli 055:B5, 5 mg/kg; Sigma). At 20 h after the injection of LPS, all of the mice were sacrificed and their duodenum tissues were collected. The blood samples were centrifuged at 5,000 rpm for 10 min, and were subsequently stored at −80°C before analysis.

Estimation of Cytokine Levels
-----------------------------

Serum levels of various cytokines were estimated by enzyme-linked immunosorbent assay (Boster, Wu han, China). All analyses were conducted as described by the manufacturer.

Duodenum Morphology
-------------------

Part of the intestinal wall of the duodenum was prepared for histological examination by fixing in 4% formaldehyde-buffered solution, embedding in paraffin, and sectioning. The tissues were then embedded in paraffin and cut into 5 μm sections used for H&E staining (Cui et al., [@B6]). Villous height and the associated crypt depth were evaluated as described by Nabuurs et al. ([@B23]) and Greig and Cowles ([@B12]).

Determination of Antioxidant Index in the Duodenum
--------------------------------------------------

To evaluate the provident-antioxidant balance in the duodenum, we determined total antioxidant capacity (T-AOC), the total superoxide dismutase (T-SOD), and glutathione peroxidase (GSH-Px) activities (Nanjing jiancheng Bioengineering institute). The method was describe as Fang et al. ([@B9]). The duodenum samples were thawed, weighed, and homogenized (1:10, wt/vol) in 9 volumes of ice-cold physiologic saline. The homogenates were centrifuged at 3,000 × g for 10 min at 4°C, the supernatants collected and enzyme activities analyzed.

Western Blot
------------

The proteins were extracted from frozen intestinal tissues with an extract kit according to the manufacturer\'s protocol (cat. no. P0028; Beyotime Institute of Biotechnology, Haimen, China). Protein concentration was determined using a BCA assay. Equal amounts (50 μg per lane) of protein were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 100 v for 3 h electrophoretic ally transferred to nitrocellulose/polyvinyl lidenedifluoride membranes (Pierce Biotechnology, Rockford, IL/Bio-Rad Laboratories, Hercules, CA), and blocked for 1 h in phosphatebuffered saline containing Tween 20 (0.1%) and non-fat milk (5%). The membranes were incubated overnight at 4°C with rabbit anti-mouse polyclonal antibodies to NF-κB (1:1,000 dilution), β-actin (1:2,000 dilution). After washing for three times with Tris-buffered saline containing Tween-20, the membranes were incubated with the corresponding goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:10,000 dilutions) for 1 h at room temperature. Band intensities were measured using Image J software (National Institutes of Health).

Data Analysis
-------------

All the experimental values obtained were expressed as mean ± SD. One-way ANOVA showed significant differences among multiple group comparisons. Analysis was performed with the software SPSS version 16.0 (SPSS Inc., USA). *P* \< 0.05 was considered significant. Statistical significance was calculated by use of Student\'s *t*-test (two-group comparison).

Results {#s3}
=======

Characteristics of Compounds From the Herbal Formula GD
-------------------------------------------------------

In this study, LC-MS analysis was performed in negative and positive ion modes to obtain complete information about the chemical constitution of GD. The peak MS spectrum has been presented in [Figure 1](#F1){ref-type="fig"}. All constituents were full spectrum identified based on the accurate mass and network database Metlin. The identified compounds are shown in [Tables 1](#T1){ref-type="table"},[2](#T2){ref-type="table"}.

![The Total Ion Chromatogram of GD. **(A)** The Total Ion Chromatogram of GD (ESI+). (ESI+) represents the positive ion detection mode, in which the mass analyzer scans only positive charged ions and filters out negative charged ions to obtain positive charged ions information during the detection process. **(B)** The Total Ion Chromatogram of GD (ESI--). (ESI--) denotes the negative ion detection mode, in which the mass analyzer scans only negative charged ions and filters out positive charged ions, thus obtaining the information of negative charged ions.](fphar-10-00180-g0001){#F1}

###### 

Chemical components identified from GD by high-performance liquid chromatography-electrospray ionization/mass spectrometry (ESI+).

  **Name**                                       **Rt (min)**   **Molecular weight**   **CAS**       **Content (ng/μL)**
  ---------------------------------------------- -------------- ---------------------- ------------- ---------------------
  L-Phenylalanine                                2.983          165.0785               63-91-2       79.79
  L-Arginine                                     1.201          174.111                74-79-3       6.23
  L-Tyrosine                                     1.397          181.0732               60-18-4       6.58
  L-Glutamate                                    1.313          147.0525               56-86-0       1.72
  L-Isoleucine                                   2.072          131.0941               61-90-5       28.07
  L-Lysine                                       1.16           146.1049               56-87-1       0.21
  L-Proline                                      1.341          115.0628               147-85-3      3.61
  Pyroglutamic acid                              1.98           129.042                98-79-3       7.89
  Ferulic acid                                   4.69           194.0573               1135-24-6     18.63
  Sinapic acid                                   4.66           224.0675               530-59-6      43.02
  Styrene                                        6.038          104.0621               100-42-5      0.39
  Chorismic acid                                 3.906          226.0474               617-12-9      4.24
  m-Coumaric acid                                4.64           164.0467               588-30-7      78.65
  1,2,3-Trihydroxybenzene                        3.232          126.0311               533-73-3      0.78
  Caffeic Acid                                   4.48           180.0415               4607-41-4     3.03
  Thymol                                         4.451          150.1038               89-83-8       15.89
  Adenosine                                      1.965          267.0958               58-61-7       60.13
  Adenine                                        1.957          135.0546               73-24-5       0.06
  Guanosine                                      1.96           283.0908               118-00-3      3.02
  Guanine                                        1.441          151.0487               73-40-5       1.98
  cAMP                                           1.473          329.0502               60-92-4       11.12
  Quercetin 3-galactoside                        4.491          464.0946               482-36-0      3.94
  Arcapillin                                     5.282          360.0832               NA            9.50
  Glyceollin                                     5.928          338.1144               NA            0.02
  Isorhamnetin                                   4.954          316.0571               480-19-3      0.65
  Malvidin                                       5.267          330.0727               643-84-5      2.13
  Naringenin                                     5.177          272.0675               480-41-1      0.07
  Quercetin                                      4.988          302.0415               117-39-5      1.27
  Quercetin 3-(3-p-coumaroylglucoside)           4.653          610.1301               76211-70-6    0.12
  Rhamnetin                                      5.528          316.0572               480-19-3      0.03
  Taxifolin                                      4.405          304.0572               480-18-2      0.09
  Cyanidin 3-O-rutinoside                        4.334          594.1558               28338-59-2    0.29
  Diosmetin                                      5.179          300.0621               520-34-3      0.51
  Eriodictyol                                    4.51           288.0621               552-58-9      0.11
  Genistein                                      4.478          270.0516               446-72-0      0.15
  Genistin                                       4.476          432.1037               529-59-9      0.30
  Luteolin                                       4.806          286.0465               491-70-3      1.53
  Pelargonidin 3-O-(6-O-malonyl-β-D-glucoside)   4.525          518.1035               165070-68-8   0.08
  Pelargonidin 3-O-rutinoside                    4.389          578.1612               NA            0.72
  Petunidin 3-O-glucoside                        4.537          478.1092               6988-81-4     0.09
  Quercitrin                                     4.503          448.0987               522-12-3      1.07
  Sakuranin                                      4.532          448.1351               NA            0.10
  Scutellarein 5-glucuronide                     4.501          462.0778               NA            0.25
  Naringin                                       4.482          580.1763               10236-47-2    0.64
  Gallocatechin                                  1.388          306.0707               NA            4.92
  Peonidin 3-rhamnoside 5-glucoside              13.76          609.1748               53859-11-3    0.26
  Hesperetin                                     4.538          302.0778               520-33-2      0.58
  2-Hexyl-3-phenyl-2-propenal                    5.773          216.1506               101-86-0      0.98
  DL-pipecolic acid                              1.925          129.0785               535-75-1      3.26
  Hydroquinidine                                 4.963          326.1984               1435-55-8     0.03
  Hypoxanthine                                   1.963          136.0379               68-94-0       0.25
  Trigonelline                                   1.584          137.0471               535-83-1      0.63
  Xanthosine                                     4.474          284.0787               146-80-5      0.20
  Caffeine                                       4.413          194.0837               58-08-2       0.10
  D-Mannitol                                     1.231          182.0785               69-65-8       0.72
  a-L-Rhamnose                                   1.239          164.0679               6014-42-2     0.83
  Gibberellin A53                                5.402          348.1923               NA            0.08
  Glutinosone                                    5.699          220.1455               55051-94-0    0.37
  Plaunol B                                      4.789          356.1247               69749-00-4    2.28
  Quillaic acid                                  6.58           486.3329               631-01-6      8.02
  Genipin                                        4.406          226.083                6902-77-8     12.45
  Medicagenic acid                               6.215          502.327                599-07-5      5.55
  p-Cymene                                       4.894          134.1089               NA            0.56
  Pantothenic Acid                               3.524          219.1103               137-08-6      59.57
  Pyridoxine                                     2.326          169.0736               65-23-6       1.04
  Pyridoxal                                      3.258          167.0579               66-72-8       0.09
  Niacin                                         5.633          123.0314               59-67-6       0.09
  Niacinamide                                    1.985          122.0473               98-92-0       7.07
  Palmitic amide                                 9.57           255.2558               629-54-9      8.89
  13Z-Docosenamide                               13.06          337.3334               112-84-5      20.22
  Oleamide                                       9.873          281.2709               301-02-0      34.54
  Stearamide                                     12.982         283.2865               124-26-5      1.67
  Coumarin                                       5.111          146.0362               91-64-5       1.58
  3 Hydroxycoumarin                              3.902          162.0309               939-19-5      10.58
  Scopoletin                                     4.766          192.0414               NA            3.25
  Benzoic acid                                   4.7            122.0362               65-85-0       0.50
  α-ketoisovaleric acid                          1.86           116.0469               759-05-7      1.07
  Succinic acid                                  1.957          118.0273               110-15-6      14.87
  nandrolone                                     5.468          274.1923               434-22-0      1.36
  α-Linolenic Acid                               7.357          278.224                463-40-1      2.15
  Butyric acid                                   1.866          88.0521                107-92-6      2.26
  LysoPC (16:0)                                  7.257          495.3313               NA            9.12
  MG (0:0/18:3/0:0)                              6.214          352.2602               NA            1.28
  Indoleacrylic acid                             4.278          187.0625               1204-06-4     25.29
  Methyl cinnamate                               3.805          162.0675               103-26-4      15.33
  5-Hydroxy-L-tryptophan                         2.276          220.0845               4350-09-8     7.11
  Indoleacetaldehyde                             2.371          159.0681               NA            0.98
  Acetylcholine                                  2.005          145.1099               51-84-3       0.04
  Cinnamic acid                                  3.612          148.0521               621-82-9      5.94
  Gingerol                                       5.765          294.182                58253-27-3    1.93
  Hippuric acid                                  4.356          179.0576               495-69-2      0.28
  Jasmolone                                      5.898          180.1144               54383-66-3    5.56
  (-)-Jasmonic acid                              5.713          210.1247               6894-38-8     0.04
  Indole                                         4.301          117.0573               120-72-9      19.62
  Methyl jasmonate                               4.519          224.1403               39924-52-2    12.53
  Phenylacetic acid                              4.746          136.0518               103-82-2      2.22
  Acetophenone                                   4.403          120.0568               98-86-2       148.13
  Choline                                        9.289          103.0991               62-49-7       2.23
  Tropic acid                                    4.458          166.065                552-63-6      0.28

###### 

Chemical components identified from GD by high-performance liquid chromatography-electrospray ionization/mass spectrometry (ESI--).

  **Name**                               **Rt (min)**   **Molecular weight**   **CAS**      **Content (ng/μL)**
  -------------------------------------- -------------- ---------------------- ------------ ---------------------
  L-Isoleucine                           2.06           131.09469              61-90-5      69.85
  L-Phenylalanine                        2.933          165.07893              63-91-2      1577.95
  Pyroglutamic acid                      1.991          129.04272              98-79-3      130.58
  L-Cystine                              4.179          240.02653              56-89-3      29.79
  Chlorogenic Acid                       4.127          354.09478              327-97-9     6.83
  ferulic acid                           4.705          194.0574               1135-24-6    67.37
  Sinapic acid                           4.68           224.06787              530-59-6     1442.50
  1,2,3-Trihydroxybenzene                3.154          126.03172              533-73-3     406.95
  Caffeic Acid                           3.013          180.04208              4607-41-4    13.88
  Gallic acid                            3.708          170.02138              149-91-7     75.26
  Gentisic acid                          3.623          154.0266               490-79-9     418.77
  Shikimic acid                          1.836          174.05273              138-59-0     1125.65
  Homogentisic acid                      3.694          168.04204              451-13-8     92.70
  m-Coumaric acid                        4.65           164.04712              588-30-7     85.87
  Syringic acid                          2.887          198.05249              530-57-4     259.47
  Salicylic acid                         4.496          138.03141              69-72-7      186.01
  Uridine                                2.02           244.06907              58-96-8      29.12
  Inosine                                1.276          268.07889              58-63-9      1744.91
  IMP                                    4.452          348.04661              131-99-7     5.67
  cAMP                                   1.971          329.05183              60-92-4      12.55
  Diosmetin                              5.179          300.06245              520-34-3     10.54
  Genistein                              4.566          270.05208              446-72-0     5.29
  Malvidin                               5.272          330.07307              643-84-5     49.08
  Naringenin                             5.185          272.06776              480-41-1     5.08
  Quercetin                              5.038          302.04179              117-39-5     151.07
  Cyanidin 3-O-rutinoside                4.326          594.15626              28338-59-2   215.56
  Isorhamnetin                           4.948          316.05741              480-19-3     28.09
  Luteolin                               4.861          286.04682              491-70-3     98.57
  Pelargonidin 3-O-rutinoside            4.944          578.16133              NA           7.12
  Petunidin 3-O-glucoside                4.585          478.10942              6988-81-4    12.44
  Quercitrin                             4.555          448.09913              522-12-3     54.73
  Dihydromyricetin                       4.479          320.05192              27200-12-0   5.70
  Eriodictyol                            4.523          288.06209              552-58-9     6.25
  Naringin                               4.499          580.17667              10236-47-2   497.90
  Quercetin 3-(3-p-coumaroylglucoside)   4.67           610.12941              76211-70-6   5.09
  Quercetin 3-galactoside                4.519          464.09335              482-36-0     355.12
  Scutellarein 5-glucuronide             4.502          462.07786              NA           26.79
  Taxifolin                              4.43           304.05702              480-18-2     5.79
  Rutin                                  4.428          610.14931              153-18-4     869.84
  Hesperetin                             4.523          302.07789              520-33-2     7.26
  Purine                                 1.299          120.04223              120-73-0     2218.84
  2-Furoic acid                          1.439          112.01615              88-14-2      5378.42
  Caffeine                               4.492          194.08423              58-08-2      8.44
  D-Glucarate                            1.543          210.03737              87-73-0      1339.49
  D-Glucuronic acid                      1.264          194.04247              6556-12-3    465.85
  Glutaric acid                          1.311          132.04226              110-94-1     14780.91
  L-Xylulose                             1.458          150.05294              527-50-4     77.69
  D-Mannitol                             1.265          182.07878              69-65-8      3230.88
  Gluconic acid                          1.299          196.058                526-95-4     15723.38
  α-D-Glucose                            1.307          180.06317              492-62-6     2610.07
  α,α-Trehalose                          1.738          342.1154               57-50-1      694.30
  Raffinose                              4.067          504.16731              512-69-6     9.04
  Genipin                                4.414          226.08368              6902-77-8    1182.88
  Gibberellin A12                        8.093          332.19787              NA           7.66
  Medicagenic acid                       6.193          502.32825              599-07-5     5112.01
  Quillaic acid                          6.564          486.33328              631-01-6     2459.37
  Rishitin                               7.443          222.16141              18178-54-6   495.43
  Gibberellin A17                        4.924          378.1664               18411-79-5   48.05
  Gibberellin A36                        5.465          362.17181              NA           56.04
  Ganoderic acid H                       17.348         572.2945               98665-19-1   391.13
  Geranyl diphosphate                    4.391          314.06284              763-10-0     9.75
  Pantothenic Acid                       3.485          219.1103               137-08-6     1709.46
  Riboflavin                             4.246          376.1359               83-88-5      416.48
  Sulfuric acid                          1.575          97.96744               7664-93-9    5308.81
  Phosphoric acid                        1.471          97.97696               7664-38-2    473.05
  Benzoic acid                           4.717          122.03673              65-85-0      171.79
  Citric acid                            1.446          192.02674              77-92-9      56678.22
  Lactic acid                            2.959          90.0318                50-21-5      37.83
  Pyruvate                               1.45           88.01615               127-17-3     1368.82
  Hexadecanedioic acid                   5.656          286.21382              NA           37.39
  Quinic acid                            4.373          192.06302              77-95-2      1839.95
  Aconitic acid                          2              174.0164               499-12-7     1098.77
  Itaconic acid                          2.512          130.02669              97-65-4      344.08
  Maleic acid                            1.996          116.01102              110-16-7     192.83
  Malic acid                             1.879          134.02155              6915-15-7    13050.35
  Oxoglutaric acid                       1.487          146.02162              328-50-7     1208.40
  Succinic acid                          2.072          118.02664              110-15-6     8700.38
  Glyceric acid                          1.354          106.02678              473-81-4     223.93
  Nandrolone                             5.46           274.19264              434-22-0     7.66
  α-Linolenic Acid                       7.321          278.22397              463-40-1     140.85
  LysoPC(15:0)                           7.22           481.31539              NA           978.13
  Traumatic Acid                         5.273          228.13561              6402-36-4    66.26
  Acetophenone                           4.646          120.05742              98-86-2      42.39
  Citramalic acid                        1.499          148.03727              2306-22-1    1513.97
  Mevalonic acid                         3.028          148.07363              150-97-0     44.67
  Phenylacetic acid                      4.741          136.05243              103-82-2     150.15
  (-)-Jasmonic acid                      5.711          210.12533              6894-38-8    5.62
  Malonic acid                           1.474          104.0111               141-82-2     304.15
  Xanthoxin                              6.275          250.15644              8066-07-07   8.61
  Gentisin                               4.621          258.05214              437-50-3     38.04
  Tropic acid                            4.432          166.06257              552-63-6     341.15
  Xanthoxic acid                         9.992          266.15443              NA           39.28

Serum Concentrations of Cytokine
--------------------------------

Compared with the control group, the concentration of inflammatory cytokine IL-1, IL-6, IL-8, and TNF-α in the LPS model group were significantly higher (*P* \< 0.05). The level of IL-1, IL-6, IL-8, and TNF-α in the low, medium and high dose GD-treated group were significantly lower than that of the LPS group with a dose-dependent manner (*P* \< 0.05). IL-2 was contrary to the changes of other inflammatory cytokines ([Figure 2](#F2){ref-type="fig"}). In addition, compared with the control group, the concentration of anti-inflammatory cytokine IL-4, and IL-10 were significantly reduced in the LPS model group in the serum (*P* \< 0.05). Compared with the LPS model group, the level of IL-4 and IL-10 in the low, medium and high dose GD-treated group were gradually increased with a dose-dependent manner and significant difference (*P* \< 0.05). However, IL-13 was contrary to the changes of other anti-inflammatory cytokines ([Figure 3](#F3){ref-type="fig"}).

![Effects of GD on the production of inflammatory cytokines in the serum. The data are expressed as the mean ± SD (*n* = 10 per treatment group). The values with same superscript letters between groups are of no significant difference (*P* \> 0.05), those with same letters are of significant difference (*P* \< 0.05). Interleukin (IL)−1, IL-2, IL-6, IL-8, and Tumor necrosis factor (TNF)-α.](fphar-10-00180-g0002){#F2}

![Effects of GD on the production of anti-inflammatory cytokines in the serum. The data are expressed as the mean ± SD (*n* = 10 per treatment group). The values with same superscript letters between groups are of no significant difference (*P* \> 0.05), those with different letters are of significant difference (*P* \< 0.05). Interleukin (IL)−4, IL-10, and IL-13.](fphar-10-00180-g0003){#F3}

Histopathological Changes in Duodenum Tissue
--------------------------------------------

The microscopic morphology was observed with HE staining. The pathological changes were obvious in the duodenum ([Figure 4](#F4){ref-type="fig"}). Compared to the control animals, LPS-treated groups caused significant mucosal damage, and that is, epithelial shedding, villi fracturing, mucosal atrophy, edema and the villus had shortened. The length of duodenal villi in GD medium and high dose groups increased significantly compared with that in LPS group (*P* \< 0.05), and the degree of intestinal mucosal injury was significantly lower than that in LPS group. Under the light microscope, the degree of duodenal mucosal injury was graded according to the standard (Chiu et al., [@B3]). The score of intestinal mucosal injury in each group was shown in [Table 3](#T3){ref-type="table"}. Compared with LPS group, the damaged level of intestinal mucous membrane was slighter than that of medium and high dose groups.

![Photomicrographs of mice duodenum tissues. **(a)** Control group, **(b)** LPS group, **(c)** GD low-dose group, **(d)** GD medium-dose group, and **(e)** GD high-dose group. Histological appearance of mice intestinal mucosa after hematoxylin and eosin (H&E) stain (original magnification 100×). Scale bars: 50 μm.](fphar-10-00180-g0004){#F4}

###### 

Effects of GD on the morphological structure of duodenum in the mice.

  **Groups**   **VH**              **CD**              **V/C**           **Mucosal injury**
  ------------ ------------------- ------------------- ----------------- --------------------
  LPS          151.34 ± 15.26^A^   74.75 ± 7.42^A^     2.32 ± 0.52^A^    4.32 ± 0.42^A^
  Low          175.25 ± 19.07^A^   62.88 ± 12.30^AB^   2.56 ± 0.70^A^    3.97 ± 0.34^A^
  medium       213.00 ± 29.91^B^   60.38 ± 6.22^AB^    3.46 ± 1.46^AB^   2.65 ± 0.24^B^
  High         246.5 ± 16.62^B^    54.12 ± 3.25^B^     4.36 ± 0.15^BC^   1.23 ± 0.28^C^
  Control      272.53 ± 24.65^B^   53.75 ± 2.84^B^     5.47 ± 0.78^C^    0.54 ± 0.02^D^

*The data are expressed as the mean ± SD (n = 10 per treatment group). VH (villus height), CD (crypt depth), and V/C (villus height/crypt depth). Grade of intestinal mucosal injury. Grade 0, normal mucosa; Grade 5, the most extensive denudation of mucosa. The difference between groups was significantly different in different capitals*.

Histomorphological Analyses
---------------------------

As shown in [Table 3](#T3){ref-type="table"}, compared with the normal group, the Villus height (VH) and ratio of villus height to crypt depth (V/C) decreased significantly in LPS group. In addition, the VH decreased significantly in low dose group. The crypt depth (CD) was higher in the GD treatment group than that of control group, but lower than that of LPS group. The VH in high dose group decreased slightly, and the CD and V/C were not significantly different from those in normal group, which was significantly higher than that in LPS group.

Antioxidant Indicators in the Duodenum
--------------------------------------

As the [Figure 5](#F5){ref-type="fig"} shows, compared with the control, the activities of the T-AOC, T-SOD, and GSH-Px significantly decreased in the LPS and low dose group, however, there was no significantly difference in high dose group. In addition, the content of T-AOC, T-SOD, and GSH-Px in each GD treatment group was higher than that in the LPS group. Moreover, in the process of the dose increased, the enzyme activity was significantly increased.

![Effects of GD on the antioxidant status of duodenum in the mice. The data are expressed as the mean ± SD (*n* = 10 per treatment group). The total superoxide dismutase (T-SOD), total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px). The values with same letters between groups are of no significant difference (*P* \> 0.05), those with different letters are of significant difference (*P* \< 0.05).](fphar-10-00180-g0005){#F5}

Effects of GD on NF-κB Expression
---------------------------------

To evaluate the effects of GD on expression of NF-κB, the level of NF-κB in duodenum were assayed ([Figure 6](#F6){ref-type="fig"}). In the GD treatment group and control group, the expression of NF-κB was lower significantly (*P* \< 0.05) than in LPS group. In addition, in the GD low and medium dose groups the expression of NF-κB was higher significantly (*P* \< 0.05) than in control group, however, there was no significantly difference in high dose group. In our present study, Western blot analysis revealed that GD can modify NF-κB activity.

![Effects of GD on NF-κB signaling pathway activation. Western blot analysis was used to assess the expression of NF-κB from each group and quantitated protein band intensities presented as β-actin normalized mean values. Representative western blot images and quantified expression levels are presented. Values are expressed as the mean ± standard deviation (*n* = 10). The values with same letters between groups are of no significant difference (*P* \> 0.05), those with different letters are of significant difference (*P* \< 0.05). NF-κB, nuclear factor-κB.](fphar-10-00180-g0006){#F6}

Discussion {#s4}
==========

Complete function of intestinal mucosa is essential for health and survival (Liu et al., [@B17]). As the main mediator between pathogen and intestinal tract, intestinal epithelial cells play an important role in the defense of pathogens (Qian et al., [@B26]). The function of intestinal epithelial cells depends on the homeostasis of intestinal mucosa. There is growing evidence that the balance between intestinal epithelial cells and the immune system maintains intestinal health (Maloy and Powrie, [@B20]). We studied whether GD could improve LPS-induced inflammation in mice. In the current experiment, we employed LPS as an inflammatory agent to establish a model of intestinal injury in mice. LPS challenge increased the level of TNF-α, IL-1, IL-6, and IL-8 in the serum ([Figure 2](#F2){ref-type="fig"}). Importantly, GD reduced the concentrations of TNF-α, IL-1, IL-6, and IL-8 in the serum, compared to LPS-challenged mice. These findings indicate that the GD has beneficial effects in reducing intestinal mucosal inflammation. The level of IL-2 has a positive correlation with cellular immune function, and it can also improve the immune defense and immune repair ability of cells. Many studies have shown that the decrease of IL-2 can lead to cellular immune dysfunction (Boyman et al., [@B1]). In the GD treatment groups the level of IL-2 was significantly enhanced, indicating that the level of IL-2 increased the immune function of T cells, thus inhibiting the inflammation in the intestine. IL-10 has multiple functions such as immunomodulation and anti-inflammatory effects (da Silva et al., [@B7]). In this study, the expression level of IL 10 in the serum of the model group mice was lower than that of the control group, indicating that the expression level of IL-10 was negatively correlated with the degree of inflammation. The GD played a significant role in regulating IL-10 level, and increased with the increase of GD concentration ([Figure 3](#F3){ref-type="fig"}). Importantly, significant correlation between NF-κB activity and concentrations of pro-inflammatory mediators was revealed in intestine (Zuo et al., [@B36]). The activation of NF-κB leads to production of pro-inflammatory molecules. Previous studies show that *Gardenia jasminoides* Ellis and Crocus sativus L could decrease NF-κB and inflammation (Xu et al., [@B33]). Our results showed that LPS significantly increased the expression of NF-κB, while blockade of GD significantly abolished these effects ([Figure 5](#F5){ref-type="fig"}). GD significantly regulates the imbalance between pro-inflammatory and anti-inflammatory factors in the duodenum tissue of mice, down regulates the state of local immunoreaction and alleviates the damage of mucosal inflammation, which may be one of the mechanisms for the treatment of intestinal mucosal damage.

The complete structure of the small intestine is the physiological basis of its digestion and absorption function, and its morphological and structural changes directly affect the surface area of villi, thereby affecting the body\'s ability to absorb nutrients (Collins and Bhimji, [@B4]). VH, CD, and V/C can be regarded as a criterion to reflect the intestinal mucosal morphology and the absorption capacity of the small intestine (Greig and Cowles, [@B12]). VH and CD of intestinal mucosa are closely related to animal digestion. Detection of VH and CD can judge the degree of intestinal mucosal damage and the ability to repair (Dong et al., [@B8]). Thus, an increase in VH, V/C or decrease in the CD corresponds to an improvement in the digestion and absorption of nutrients (Hou et al., [@B15]). Accordingly, GD increased V/C and VH in the duodenum and decreased the VH, compared to the LPS mice. The result of serum metabolites ([Figure 1](#F1){ref-type="fig"}) was also in agreement with the alteration of intestinal villus structure. These results indicated that GD has inhibitory effect on the intestinal mucosal damage in mice, and the inhibitory effect exhibits a dose-dependent manner.

HPLC analysis identified the main components-amino acids, organic acids, fatty acids, nucleosides, flavonoids and so on-included in GD. Geniposide, the major iridoid glycoside ingredient of gardenia herbs, has emerged as a novel multifunctional tissue-protective agent with antioxidant (Fu et al., [@B10]) and anti-inflammatory effects (Lee et al., [@B16]). SOD is an important enzyme system for scavenging oxygen free radicals, which has protective effect on cell damage. SOD can prevent the expansion of oxidation free radical chain reaction. It can be considered as an important line of oxygen free radical scavenging system in organism (Mansuroglu et al., [@B21]). GSH-PX catalyzes the redox reaction of the prototype GSH to the hydroperoxide, which can remove the harmful peroxide metabolites in the cells and block the lipid peroxidation chain reaction, thus protecting the membrane structure and function integrity of the cell (Gordeeva et al., [@B11]). The results of the experiment were that the content of T-AOC in GD treatment groups was higher than that of the model group, and there was a significant difference. The expression of T-SOD and GSH-Px in the GD treatment groups was significantly increased in the duodenum tissue and there was a significant difference ([Figure 6](#F6){ref-type="fig"}). It is indicates that GD has the ability to protect the intestinal epithelial cells from oxygen free radical damage.

Conclusion {#s5}
==========

*Gardenia jasminoides* can promote tissue repair by inhibiting the expression of inflammatory factors, lowering the disease activity and deceasing intestinal mucosal damage. It could be important for intervening the cycle of inflammation associated with intestinal mucosal injury. Further studies of GD are necessary to develop a new effective plant-derived therapeutic modality for intestinal mucosal injury.
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